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Experiment details
Reagents and DNA plasmids construction.
IAA was purchased from Sigma (Cat# I3750). ABA was purchased from Gold Biotechnology (Cat# A-050-5). Polyethylenimine (PEI, Polyscienses) was employed as transfection reagent. All 
MTT assay.
CHO cells were plated into 96-well plate and were cultured overnight. Cells were treated with IAA at different concentrations, as well as DMSO mock. Cells were subjected MTT assay 24 hours after IAA treatment, which was conducted as described in our previous publication. 3
Fluorescence microscopy.
The fluorescence imaging was conducted by Zeiss Axio Observer D1 outfitted with HBO 100 microscopy illumination system. EGFP was excited at 470/40 nm and emitted fluorescence at 525/50 nm. Images were taken with GFP channel accordingly.
Cytotoxicity assay and quantification of secreted TRAIL.
For sTRAIL apoptotic assays, 293T cells were transfected to express the IAA-responsive split transcriptional activator and 5xGal4 response elements controlling the expression of sTRAIL.
Cell culture supernatant containing sTRAIL was collected after 24 h treated with either IAA 250 M or mock DMSO and incubated with TRAIL-sensitive MDA-MD-231 cancer cell lines for another 24 h. Cell viability and apoptosis were accessed using the Dead Cell Apoptosis Kit with Annexin V-FITC and PI, for flow cytometry according to the manufacturer's protocol (Invitrogen #V13242). Briefly, cancer cells were harvested by trypsinization at 24 h after drug treatment and were washed twice with cold PBS. Then 106 cells, suspended in Annexin V binding buffer, were incubated with Propidium Iodide and FITC-Annexin V to a final concentration of 1 g/mL, 1:20 volume ratio, respectively, for 15 minutes at room temperature in
